Legend Biotech Corp. (LEGN)
19.27
+0.37
(+1.96%)
USD |
NASDAQ |
Oct 23, 16:00
19.26
-0.01
(-0.05%)
After-Hours: 20:00
Legend Biotech Market Cap : 3.734B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.734B |
| October 22, 2026 | 3.662B |
| October 21, 2026 | 3.610B |
| October 20, 2026 | 3.684B |
| October 19, 2026 | 3.614B |
| October 16, 2026 | 3.581B |
| October 15, 2026 | 3.837B |
| October 14, 2026 | 3.689B |
| October 13, 2026 | 3.465B |
| October 12, 2026 | 3.449B |
| October 09, 2026 | 3.608B |
| October 08, 2026 | 3.625B |
| October 07, 2026 | 3.705B |
| October 06, 2026 | 3.627B |
| October 05, 2026 | 3.638B |
| October 02, 2026 | 3.598B |
| October 01, 2026 | 3.744B |
| September 30, 2026 | 3.854B |
| September 29, 2026 | 3.647B |
| September 28, 2026 | 3.608B |
| September 25, 2026 | 3.703B |
| September 24, 2026 | 3.693B |
| September 23, 2026 | 3.575B |
| September 22, 2026 | 3.612B |
| September 21, 2026 | 3.591B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.412B |
| September 17, 2026 | 3.406B |
| September 16, 2026 | 3.294B |
| September 15, 2026 | 3.424B |
| September 14, 2026 | 3.591B |
| September 11, 2026 | 3.612B |
| September 10, 2026 | 3.718B |
| September 09, 2026 | 3.858B |
| September 08, 2026 | 3.970B |
| September 04, 2026 | 4.170B |
| September 03, 2026 | 4.214B |
| September 02, 2026 | 4.242B |
| September 01, 2026 | 4.094B |
| August 31, 2026 | 4.027B |
| August 28, 2026 | 3.852B |
| August 27, 2026 | 3.972B |
| August 26, 2026 | 4.007B |
| August 25, 2026 | 4.127B |
| August 24, 2026 | 4.058B |
| August 21, 2026 | 4.228B |
| August 20, 2026 | 4.120B |
| August 19, 2026 | 4.379B |
| August 18, 2026 | 4.247B |
| August 17, 2026 | 4.001B |
| August 14, 2026 | 3.947B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 193.65B |
| Ionis Pharmaceuticals, Inc. | 7.111B |
| Johnson & Johnson | 635.02B |
| Arbutus Biopharma Corp. | 830.06M |
| Capricor Therapeutics, Inc. | 344.59M |
Market Cap Related Metrics
| PS Ratio | 2.829 |
| Price to Book Value | 3.037 |
| Price | 19.27 |
| Earnings Yield | -2.62% |